IRS4 and breast carcinoma: Ectopic expression of Irs4 in human HER2+ breast cancer cell lines SKBR3 and BT474, clearly induced resistance to Trastuzumab and Lapatinib (Fig. 7d,e; Supplementary Fig. 8d–f).